Huberman on the Emerging Science Around Psychedelics

TL;DR

Psychedelic medicine, including compounds like psilocybin and MDMA, is gaining traction in the medical community for its potential to treat depression and other mental illnesses.

Transcript

The Joe Rogan Experience this is now really big science and Pharma is moving in very quickly what they're trying to do is create non-psychedelic psychedelics figure out what sorts of chemistry changes that doesn't give you hallucinations and create new antidepressants that's what they want to do with psilocybin because doing two Journeys on a drug ... Read More

Key Insights

• 👶 Science and Pharma are actively researching non-psychedelic psychedelics to develop new antidepressants with psilocybin.
• ☠️ Clinical data demonstrates a high success rate in treating untreatable depression with psychedelics.
• 🥺 Top tier donors' increasing interest in psychedelics has led universities to discuss and explore this field.
• 🛀 Psychedelic medicine shows promise in treating various mental illnesses, such as PTSD, depression, anorexia, and ADHD.
• 👨‍🔬 Research on the safety profiles of MDMA suggests minimal neurotoxicity when pure and not contaminated.
• 💱 Public perception of psychedelics has changed significantly over the last decade, with more positive stories reaching a broader audience.
• 🤕 Psychedelic medicine is heading towards mainstream acceptance, thanks to the efforts of researchers like Michael Pollan, Robin Carhart-Harris, and Nolan Williams.

Questions & Answers

Q: What is the motivation behind creating non-psychedelic psychedelics?

The goal is to discover chemical changes that eliminate hallucinations to develop new antidepressants with improved efficacy and profitability.

Q: Why are universities now open to discussing psychedelics?

Top tier donors, who provide crucial funding, have become interested in psychedelics, influencing universities to explore this field.

Q: What types of mental illnesses have shown positive responses to psychedelic medicine?

Psychedelics have shown potential in treating untreatable depression, PTSD, anorexia, ADHD, and other psychiatric illnesses.

Q: What are the safety profiles of MDMA?

Studies on individuals, particularly among the Mormon population, who have taken MDMA consistently show minimal neurotoxicity when the drug is not contaminated.

Summary & Key Takeaways

• Science and Pharma are exploring non-psychedelic psychedelics to create new antidepressants with psilocybin, as clinical data shows a 65+ success rate in treating untreatable depression.

• Universities are now discussing psychedelics with top tier donors, who are increasingly interested in funding research in this field.

• Psychedelic medicine has shown promise in treating PTSD, depression, anorexia, ADHD, and other psychiatric illnesses.